BOSTON ADVISORS LLC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 14 filers reported holding Astellas Pharma Inc in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BOSTON ADVISORS LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2019$161,000
-74.2%
11,295
-74.3%
0.01%
-75.8%
Q2 2019$625,000
-5.0%
43,9660.0%0.03%
-2.9%
Q1 2019$658,000
+37.9%
43,966
+15.7%
0.03%
+21.4%
Q4 2018$477,000
-23.3%
38,003
+6.7%
0.03%
+3.7%
Q3 2018$622,000
+15.2%
35,632
+0.0%
0.03%
+92.9%
Q2 2018$540,000
+0.7%
35,626
+1.6%
0.01%0.0%
Q1 2018$536,000
+29.5%
35,069
+7.3%
0.01%
+55.6%
Q4 2017$414,000
+2.7%
32,675
+2.8%
0.01%0.0%
Q3 2017$403,000
+3.6%
31,8000.0%0.01%0.0%
Q2 2017$389,000
-7.2%
31,8000.0%0.01%
-10.0%
Q1 2017$419,000
+39.2%
31,800
+46.2%
0.01%
+42.9%
Q4 2016$301,00021,7500.01%
Other shareholders
Astellas Pharma Inc shareholders Q4 2017
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 469,618$7,628,0000.31%
TODD ASSET MANAGEMENT LLC 193,500$3,148,0000.07%
SCOUT INVESTMENTS, INC. 225,247$3,665,0000.05%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 193,500$3,148,0000.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 113,135$1,838,0000.01%
Private Capital Group, LLC 924$15,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 35$1,0000.00%
IFP Advisors, Inc 40$1,0000.00%
First Horizon Advisors, Inc. 120$1,0000.00%
CAPTRUST FINANCIAL ADVISORS 3,790$62,0000.00%
View complete list of Astellas Pharma Inc shareholders